Neoplasm of uncertain behavior of placenta
ICD-10 D39.2 is a billable code used to indicate a diagnosis of neoplasm of uncertain behavior of placenta.
D39.2 refers to a neoplasm of uncertain behavior specifically located in the placenta. These neoplasms are characterized by their ambiguous histological features, which do not clearly indicate whether they are benign or malignant. The clinical implications of such neoplasms can be significant, as they may exhibit unpredictable behavior, including the potential for local invasion or metastasis. Diagnosis typically involves imaging studies and histopathological examination, which may reveal atypical cellular features. Surveillance is crucial, as these neoplasms can progress over time, necessitating close monitoring of the patient’s condition. Management strategies may vary based on the neoplasm's characteristics and the patient's overall health, with options ranging from observation to surgical intervention. The uncertainty surrounding these neoplasms underscores the importance of multidisciplinary care, involving obstetricians, oncologists, and pathologists to ensure comprehensive management and timely intervention if necessary.
Detailed documentation of imaging studies, pathology reports, and clinical findings related to the neoplasm.
Encountering patients with abnormal placental findings during routine ultrasounds or during evaluation for abnormal bleeding.
Ensure clear communication of the neoplasm's behavior and any follow-up plans to avoid misinterpretation.
Comprehensive documentation of treatment plans, follow-up care, and any multidisciplinary consultations.
Management of patients with diagnosed placental neoplasms requiring further evaluation or treatment.
Collaboration with obstetricians for coordinated care and accurate coding of procedures.
Used when a biopsy of the placental mass is performed to determine the nature of the neoplasm.
Pathology report detailing the findings and diagnosis.
Ensure that the pathology report is linked to the diagnosis for accurate coding.
It refers to a growth that cannot be definitively classified as benign or malignant based on histological examination, necessitating careful monitoring and evaluation.
